Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srinivasan Dasarathy

Showing results (11-20 of 233) with videos related to

Pageof 24
Sort By:
Alcohol, Clinical & Experimental Research|December 28, 2023
Fuel to the fire: The impact of COVID-19 on alcohol-associated hepatitisShreya Sengupta, Srinivasan Dasarathy
Journal of Hepatology|August 13, 2016
Sarcopenia from mechanism to diagnosis and treatment in liver diseaseSrinivasan Dasarathy, Manuela Merli
Journal of Hepatology|May 30, 2015
Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?Manuela Merli, Srinivasan Dasarathy
Clinics in Liver Disease|February 11, 2012
Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responsesPranav Periyalwar, Srinivasan Dasarathy
Journal of Hepatology|February 11, 2017
Reply to: "Myokines: a promising therapeutic target for hepatic encephalopathy"Srinivasan Dasarathy, Manuela Merli
Current Opinion in Clinical Nutrition and Metabolic Care|October 17, 2017
Hyperammonemia and proteostasis in cirrhosisSrinivasan Dasarathy, Maria Hatzoglou
Journal of Hepatology|July 13, 2004
Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma?Kevin D Mullen, Srinivasan Dasarathy
Current Treatment Options in Gastroenterology|November 7, 2001
Hepatic EncephalopathySrinivasan Dasarathy, Kevin D. Mullen
Current Infectious Disease Reports|February 15, 2001
Recent Advances in SchistosomiasisG. Richard Olds, Srinivasan Dasarathy
Alcoholism, Clinical and Experimental Research|March 16, 2017
Alcoholic Liver Disease on the Rise: Interorgan Cross Talk Driving Liver InjurySrinivasan Dasarathy, J Mark Brown
Pageof 24

Showing results (11-20 of 233) with videos related to

Sort By:
Pageof 24
Alcohol, Clinical & Experimental Research|December 28, 2023
Fuel to the fire: The impact of COVID-19 on alcohol-associated hepatitisShreya Sengupta, Srinivasan Dasarathy
Journal of Hepatology|August 13, 2016
Sarcopenia from mechanism to diagnosis and treatment in liver diseaseSrinivasan Dasarathy, Manuela Merli
Journal of Hepatology|May 30, 2015
Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?Manuela Merli, Srinivasan Dasarathy
Clinics in Liver Disease|February 11, 2012
Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responsesPranav Periyalwar, Srinivasan Dasarathy
Journal of Hepatology|February 11, 2017
Reply to: "Myokines: a promising therapeutic target for hepatic encephalopathy"Srinivasan Dasarathy, Manuela Merli
Current Opinion in Clinical Nutrition and Metabolic Care|October 17, 2017
Hyperammonemia and proteostasis in cirrhosisSrinivasan Dasarathy, Maria Hatzoglou
Journal of Hepatology|July 13, 2004
Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma?Kevin D Mullen, Srinivasan Dasarathy
Current Treatment Options in Gastroenterology|November 7, 2001
Hepatic EncephalopathySrinivasan Dasarathy, Kevin D. Mullen
Current Infectious Disease Reports|February 15, 2001
Recent Advances in SchistosomiasisG. Richard Olds, Srinivasan Dasarathy
Alcoholism, Clinical and Experimental Research|March 16, 2017
Alcoholic Liver Disease on the Rise: Interorgan Cross Talk Driving Liver InjurySrinivasan Dasarathy, J Mark Brown
Pageof 24